ArticleAntimicrobial agents and chemotherapy2006

Clinical correlation of the CLSI susceptibility breakpoint for piperacillin- tazobactam against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella species.

Patrick J Gavin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.